A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This is a randomized, double-blind, placebo-controlled study with an open-label extension (OLE).
Epistemonikos ID: 27236c60e17e6bec50ffb526cbe2f8a568adf228
First added on: Oct 02, 2023